Vaxxinity

IPO

Vaxxinity is a biotech company in Dallas, United States, founded in 2021. It has raised $14.2M across 3 rounds, most recently a $9.3M Grant in April 2022.

Headquarters
Dallas, Texas
Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$14.2M
Last Round
$9.3M GrantApr 2022
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health, with a focus on developing peptide-based therapeutic vaccines for chronic diseases including Alzheimer's, Parkinson's, and COVID-19. Formed in 2021 through the combination of COVAXX and United Neuroscience, the company is headquartered in Dallas, Texas, and uses an immune-system-based approach to deliver vaccines that are cost-effective, long-lasting, and effective against emerging variants without requiring cold-chain mRNA technology. Vaxxinity's mission is to make high-quality biologic medicines accessible to people around the world by replacing expensive injectable biologics with affordable vaccine alternatives.

Summary

It lists 51–200 employees. It has raised $14.2M in total across 3 rounds, most recently a $9.3M Grant round in Apr 2022. Investors include CEPI, BofA Securities and Jefferies.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
GrantApr 2022
$9.3M

Sign up to see all 4 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vaxxinity on Indexed.vc
<a href="https://indexed.vc/companies/vaxxinity"><img src="https://indexed.vc/api/badge/company/vaxxinity" alt="Vaxxinity on Indexed.vc" width="260" height="76" /></a>